Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58091171
Abstract: Background and Objectives: Warfarin and a skeletal muscle relaxant are co-treatments in nearly a quarter-million annual United States (US) office visits. Despite international calls to minimize patient harm arising from anticoagulant drug interactions, scant data… read more here.
Keywords: warfarin treated; users warfarin; muscle relaxants; muscle ... See more keywords